NCT00130871View on ClinicalTrials.gov

Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

January 31, 2006

Conditions
Coronary Heart Disease
Interventions
DRUG

levosimendan

Trial Locations (2)

00290

Helsinki University Central Hospital, Helsinki

Unknown

Turku University Central Hospital, Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT00130871 - Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass | Biotech Hunter | Biotech Hunter